Labajo, Kyle Charmaine .
HRN: 23-93-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFUROXIME 500MG (TAB)
01/03/2024
01/09/2024
PO
500mg
BID
Thickly Msaf
Waiting Final Action
01/03/2024
METRONIDAZOLE 500MG (TAB)
01/03/2024
01/09/2024
PO
1tab
TID
Thickly MSAF
Waiting Final Action